Skip to content

The effect of intravesical instillation with 5% magnesium sulfate on catheter-related bladder discomfort in male patients undergoing thoracoscopic surgery

The effect of intravesical instillation with 5% magnesium sulfate on catheter-related bladder discomfort in male patients undergoing thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116637
Enrollment
Unknown
Registered
2026-01-13
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related bladder discomfort

Interventions

Saline solution group:Intravesical instillation of 20 mL normal saline via a urinary catheter.
Magnesium Sulfate Group:Intravesical instillation of 20 mL magnesium sulfate via a urinary catheter.
Lidocaine group:Intravesical instillation of 20 mL lidocaine via a urinary catheter.

Sponsors

HenanCancerHospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male patients; 2. Scheduled for thoracoscopic surgery; 3. Aged 20-80 years; 4.Body Mass Index (BMI) 18.5–30.0 kg/m^2; 5. American Society of Anesthesiologists (ASA) physical status classification of I, II, or III; 6. Voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. Chronic kidney disease; 2. Atrioventricular block; 3. Neuromuscular diseases; 4. Hypermagnesemia (serum magnesium concentration > 3.0 mg/dL); 5. Hypocalcemia (serum calcium concentration < 8.6 mg/dL); 6. Long-term use of analgesic, sedative, or psychiatric medications; 7. Pre-existing bladder disorders: overactive bladder, bladder outlet obstruction, or neurogenic bladder; 8. History of psychiatric disorders or cognitive impairment; 9. Patients planned for postoperative transfer to the intensive care unit (ICU).

Design outcomes

Primary

MeasureTime frame
Incidence of Moderate-to-Severe Catheter-Related Bladder Discomfort (CRBD);

Secondary

MeasureTime frame
Quality of Recovery;Incidence of postoperative delirium;The incidence of urinary retention and/or urinary tract infection.;Volume of intraoperative fluid administered.;Incidence of moderate-to-severe CRBD at 1 hour, 2 hours, and 6 hours after extubation.;Patient satisfaction;The increase in urine output was measured at the following time points;The type of surgery and the total durations of anesthesia and surgery were recorded.;Visual Analogue Scale Score;Adverse reactions related to magnesium or lidocaine.;Dosage of remifentanil, dosage of flurbiprofen axetil and/or opioid drugs, and effective PCA pump compressions.;Postoperative hospital stay duration.;The time from the completion of tracheal extubation to discharge from the post-anesthesia care unit.;The mean arterial pressure and heart rate of patients;

Countries

China

Contacts

Public ContactZhan Zhen

HenanCancerHospital

zz811122@126.com+86 371 6558 8327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026